Keeping Current
Fine-Tuning Chronic Lymphocytic Leukemia Management: Optimising Bruton Tyrosine Kinase Inhibitor Use in Practice
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:34:51
- Mas informaciones
Informações:
Sinopsis
What are the latest advances shaping chronic lymphocytic leukemia (CLL) treatment today? Discover the role of Bruton tyrosine kinase (BTK) inhibitors through our expert-led journey. Credit available for this activity expires: 5/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001127?ecd=bdc_podcast_libsyn_mscpedu
